Literature DB >> 7053699

Osteomalacia after parathyroidectomy in patients with uremia.

A J Felsenfeld, J M Harrelson, R A Gutman, S A Wells, M K Drezner.   

Abstract

Five patients on maintenance dialysis had symptoms of osteomalacia, proven by biopsy, after parathyroidectomy. In all five patients clinical and radiographic manifestations of secondary hyperparathyroidism were present before surgery, and in two patients preoperative biopsy of bone confirmed the existence of osteitis fibrosa. Like previously described patients with osteomalacia all five had multiple fractures and normal or high serum calcium concentrations that rose to abnormally high values on treatment with vitamin D or dihydrotachysterol. Quantitative histomorphometry of biopsy after parathyroidectomy showed no residual parathyroid hormone effect and nearly complete cessation of mineralization. Four patients had forearm autografts of parathyroid tissue that appeared to be functioning at very low rates according to paired venous sampling, and all five patients had relatively low circulating concentrations of parathyroid hormone. This and earlier experiences reported by others suggest that secondary hyperparathyroidism may have an important facilitative role in the mineralization of bone in uremic patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7053699     DOI: 10.7326/0003-4819-96-1-34

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  Four gland parathyroidectomy without reimplantation in patients with chronic renal failure.

Authors:  R N Saunders; R Karoo; M S Metcalfe; M L Nicholson
Journal:  Postgrad Med J       Date:  2005-04       Impact factor: 2.401

2.  Inhibition of in vitro mineralization by aluminum in a clonal osteoblastlike cell line, MC3T3-E1.

Authors:  K Ikeda; T Matsumoto; K Morita; K Kurokawa; E Ogata
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

3.  Stimulation of undermineralized matrix formation by 1,25 dihydroxyvitamin D3 in long bones of rats.

Authors:  J M Hock; M Gunness-Hey; J Poser; H Olson; N H Bell; L G Raisz
Journal:  Calcif Tissue Int       Date:  1986-02       Impact factor: 4.333

4.  Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.

Authors:  M Gunness-Hey; J M Hock; I Gera; J Fonseca; J Poser; J Bevan; L G Raisz
Journal:  Calcif Tissue Int       Date:  1986-04       Impact factor: 4.333

5.  Recurrent nonsuppressible secondary hyperparathyroidism following subtotal parathyroidectomy.

Authors:  F L Polsky; M A Fullmer
Journal:  West J Med       Date:  1994-05

6.  Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up.

Authors:  Hazim M Sadideen; John D Taylor; David J Goldsmith
Journal:  Int Urol Nephrol       Date:  2011-10-14       Impact factor: 2.370

7.  Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs.

Authors:  L D Quarles; V W Dennis; H J Gitelman; J M Harrelson; M K Drezner
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

8.  Serum bone Gla protein as an indicator of parathyroidectomy in patients with secondary hyperparathyroidism.

Authors:  H Takami; J Shikata
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

Review 9.  Mineral and bone disorder after renal transplantation: a review.

Authors:  Hazim Sadideen; Adrian Covic; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2007-12-18       Impact factor: 2.370

Review 10.  Recent developments in aluminum toxicology.

Authors:  F S Monteagudo; M J Cassidy; P I Folb
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.